Table 2.
TN group (n = 20) | NR group (n = 20) | SVR group (n = 20) | Control group (n = 10) | |
---|---|---|---|---|
CD3 T-cell number/HPF | ||||
Range | 2–27 | 3–30 | 3–26 | 8–16 |
(Mean ± SD) | 13 ± 8.5 | 14.4 ± 8.3 | 11.0 ± 5.8 | 12.2 (± 2.7) |
Colonic Treg number | ||||
Range | 0–13 | 1–10 | 0–2 | 0–2 |
(Mean ± SD) | 3.5 ± 3.5 | 3.6 ± 2.6 | 0.3 ± 0.6 | 0.5 ± 0.7 |
% Colonic Treg frequency (mean ± SD) | 30.62 ± 22.13 | 25 ± 11.6 | 4.18 ± 8.6 | 3.9 ± 5.1 |
Plasma cytokine levels,† pg/mL (mean ± SD) | ||||
IL-2 | 2.61 ± 1.160 | 5.18 ± 4.35 | 3.46 ± 0.67 | 5.78 ± 7.4 |
1L-4 | 185 ± 61.69 | 143 ± 116.15 | 47 ± 28 | 34.50 ± 62.61 |
IL-10 | 18.98 ± 8.32 | 12.80 ± 9.29 | 7.75 ± 5.83 | 5.66 ± 5.746 |
TNF-α | 23 ± 11 | 22.62 ± 9.38 | 15.21 ± 3.39 | 12.66 ± 4.82 |
IFN-γ | 18.42 ± 26.37 | 17.17 ± 32.11 | 7.9115 ± 7.79 | 9.416 ± 2.23 |
The lower level of detection (LLD) for IL-2, TNF-α, and IFN-γ is (LLDs = 0.64 pg/mL) while the lower level of detection (LLD) for IL-4 and IL-10 is (LLDs = 3.2 pg/mL). Additionally, we did not consider analysis of the data if any of the cytokines levels in > 50% of the samples were below detection limit (BDL).
HPF, high-power field; IFN-γ, γ-interferon; IL, interleukin; NR, non-responders; SVR, sustained virologic response; TN, treatment naïve; TNF-α, tumor necrosis factor-α; Treg, regulatory T.